|
Market Closed -
Bombay S.E.
10:02:27 13/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 522.00 INR | +0.69% |
|
+2.85% | +8.03% |
| Market Cap | 10.46B 111M 100M 92.94M 83.86M 158M 164M 1.12B 443M 5.59B 416M 407M 17.73B | P/E 2025 |
13.4x | P/E 2026 | 12.9x |
|---|---|---|---|---|---|
| Enterprise Value | 8.09B 85.83M 77.78M 71.94M 64.91M 122M 127M 864M 343M 4.32B 322M 315M 13.72B | EV / Sales 2025 |
1.46x | EV / Sales 2026 | 1.33x |
| Free-Float |
44.95% | Yield 2025 |
0.33% | Yield 2026 | 0.32% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| LINCOLN | Delayed | |
NSE India S.E.
| LINCOLN | Delayed |
Last Transcript: Lincoln Pharmaceuticals Limited
| 1 day | +0.69% | ||
| 1 week | +2.85% | ||
| Current month | +3.99% | ||
| 1 month | -5.13% | ||
| 3 months | -15.55% | ||
| 6 months | -21.75% | ||
| Current year | +8.03% |
| 1 week | 505.9 |  | 533.75 |
| 1 month | 492.65 | | 561.1 |
| Current year | 439.95 | | 770 |
| 1 year | 439.95 | | 770 |
| 3 years | 439.95 | | 975 |
| 5 years | 255 | | 975 |
| 10 years | 85.5 | | 975 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 72 | 19/01/1995 | |
| Director of Finance/CFO | - | 27/03/2019 | |
| Chief Tech/Sci/R&D Officer | - | 28/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 19/01/1995 | |
| Chairman | 82 | 15/08/1995 | |
| Director/Board Member | 68 | 19/01/1995 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/06/24 | Buy | Director | 13,500 | 0.0674% | ||
| 03/06/24 | Buy | Director | 15,000 | 0.0749% | ||
| 03/06/24 | Buy | Director | 20,000 | 0.0999% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.69% | +2.85% | +3.34% | -12.75% | 111M | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,286B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 688B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 521B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 386B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 364B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 302B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 287B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 252B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.31% | +2.15% | +31.97% | +73.67% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.63% | +96.23% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 6.23B 66.1M 59.9M 55.4M 49.99M 94.2M 97.52M 666M 264M 3.33B 248M 243M 10.57B | 6.71B 71.17M 64.49M 59.65M 53.82M 101M 105M 717M 284M 3.58B 267M 261M 11.38B |
| Net income | 823M 8.73M 7.91M 7.32M 6.6M 12.45M 12.89M 87.94M 34.87M 440M 32.77M 32.08M 1.4B | 879M 9.32M 8.45M 7.81M 7.05M 13.29M 13.75M 93.86M 37.22M 470M 34.98M 34.24M 1.49B |
| Net Debt | -1.96B -20.76M -18.81M -17.4M -15.7M -29.58M -30.62M -209M -82.87M -1.05B -77.89M -76.24M -3.32B | -2.36B -25.06M -22.71M -21.01M -18.95M -35.72M -36.97M -252M -100M -1.26B -94.05M -92.05M -4.01B |
Employees
1,352
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | ₹522.00 | +0.69% | 1,882 |
| 12/11/26 | ₹518.40 | -0.52% | 453 |
| 11/11/26 | ₹521.10 | +0.08% | 2,116 |
| 09/11/26 | ₹520.70 | +1.26% | 1,574 |
| 08/11/26 | ₹514.20 | +1.31% | 1,930 |
- Stock Market
- Stocks
- LINCOLN Stock
Select your edition
All financial news and data tailored to specific country editions
